Combination therapy achieves improved outcomes in advanced cervical cancer
Greater tumor control and improved survival rates are seen with chemoradiation therapy in locally advanced cervical cancer.
Greater tumor control and improved survival rates are seen with chemoradiation therapy in locally advanced cervical cancer.
Colorectal tumors with mutations in the MRE11 gene may be vulnerable to PARP inhibitors, a class of drugs that has already demonstrated safety in early clinical trials of breast and ovarian cancers.
Sentinel lymph node biopsy successfully assessed lymph node status in early-stage endometrial cancer; this minimally invasive procedure may be a good alternative to lymph node removal.
The immune-boosting GOLFIG regimen increased progression-free survival in colorectal cancer so effectively that the study initiated to evaluate the treatment was prematurely terminated.
The use of talc powder in the genital area has again been linked with the development of ovarian cancer in a large study that addressed factors used to challenge earlier, similar findings.
An agent widely used to control type 2 diabetes and polycystic ovary syndrome (PCOS) could also have a role in the management of patients with endometrial cancer.
Overall, cancer incidence rates fell approximately 1% annually and overall death rates decreased by an average of 1.6% annually between 2003 and 2007.
Only a relatively small proportion of second cancers in adults is related to routine radiotherapy administered for initial disease, according to the findings of a recent study.
A study comparing health-related quality-of-life measures among three different interventions for uterine fibroids showed quality of life to increase subsequent to each treatment.
Identifying families at risk improves screening and counseling of patients at risk for hereditary nonpolyposis colorectal cancer.